Targeting Drug Delivery System for Glaucoma Surgery
Author Information
Author(s): Shao Tingting, Li Xiaoning, Ge Jian
Primary Institution: Fudan University and Sun Yat-sen University
Hypothesis
Antifibrotic agents (MMC) encapsulated in LDLr targeting drug delivery system (LDL-MMC-chitosan nanoparticles) may be proposed in anti-scarring therapy to increase the safety and effectiveness and to reduce toxicity.
Conclusion
The LDL-MMC-chitosan nanoparticles drug delivery system can effectively target activated HTFs and reduce ocular complications after glaucoma filtration surgery.
Supporting Evidence
- LDL receptors are overexpressed in activated HTFs, making them a target for drug delivery.
- Chitosan nanoparticles can protect and deliver MMC specifically to HTFs.
- The use of hyaluronic acid film can help in the gradual release of the drug at the surgical site.
Takeaway
This study suggests a new way to deliver medicine directly to the cells that cause scarring after eye surgery, which could help patients heal better.
Methodology
A chitosan-based polymeric predrug of MMC was synthesized, and its cytotoxicity was tested, along with the release rates of the drug.
Limitations
The study does not provide specific data on long-term effects or clinical trials in humans.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website